Immune Therapeutics Inc (IMUND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMUND | AMGN | BMY | VRTX | GILD |
| Company | Immune Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 5.5000 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 5.7500 | 291.11 | 58.48 | 455.43 | 89.94 |
| Low | 5.2500 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 5.2500 | 289.90 | 58.23 | 450.37 | 89.76 |
| Change | -0.4900 | +2.03 | +0.35 | -0.86 | +1.13 |
| % Change | -8.54% | +0.71% | +0.60% | -0.19% | +1.27% |
| Volume | 500 | 3,553,200 | 7,441,376 | 1,507,600 | 4,057,200 |
| 20-Day Average Volume | 1,820 | 2,922,855 | 12,398,354 | 1,345,780 | 7,529,130 |
| Previous Close | 5.7400 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.7010 | 307.42 | 55.92 | 479.24 | 90.89 |
| 20-Day Raw Stochastic | 15.76% | 27.22% | 69.26% | 7.17% | 28.71% |
| 20-Day Relative Strength | 35.24% | 36.50% | 60.71% | 40.89% | 53.58% |
| Weighted Alpha | -80.14 | +1.92 | +26.05 | +18.06 | +26.07 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 56% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.23% since 05/26/21 | -2.04% since 11/14/24 | -0.46% since 11/14/24 | -6.94% since 11/14/24 | -2.55% since 11/14/24 |
| Low | 5.2500 on 06/03/21 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 6.0000 on 05/28/21 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -62.77% since 05/03/21 | -8.47% since 10/21/24 | +11.72% since 10/21/24 | -5.80% since 10/21/24 | +4.02% since 10/21/24 |
| Low | 2.5000 on 05/10/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 85.60 on 10/22/24 |
| High | 19.9500 on 05/11/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -72.37% since 03/03/21 | -11.92% since 08/21/24 | +20.21% since 08/21/24 | -7.35% since 08/21/24 | +19.47% since 08/21/24 |
| Low | 2.5000 on 05/10/21 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.00 on 11/21/24 | 75.35 on 08/22/24 |
| High | 26.0000 on 03/10/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -65.46% since 12/03/20 | -7.92% since 05/21/24 | +37.76% since 05/21/24 | +1.89% since 05/21/24 | +33.39% since 05/21/24 |
| Low | 2.5000 on 05/10/21 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 32.7000 on 02/22/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 0 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 1,590,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 790,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.94 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 07/05/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |